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A method  based  on  the  Concentration  Derivative  Product   (CDP)   is 
proposed to analyze the thermodynamics of Drug­Receptor interactions. CDP 
is defined as the product of the fractional inhibition f and it’s concentration 
derivative.   Assuming  Michaelis­Menten   kinetics,   it   is   shown   that   for   a 









































































Inhibiting   a   vital   enzyme   involved   in   the   replication   cycle   of   a 
pathogen or a biochemical pathway is a common strategy employed in many 
drug discovery  programs  .1   Thus  inhibitors  of  HIV protease,  Angiotensin 
Converting Enzyme (ACE) illustrate this strategy.1 Detailed knowledge of the 
receptor helps in the a­priori design of the inhibitors. 2­15 . Design based on the 
three   dimensional   structure   of   the   target   protein       has   gained   some 
prominence.5­9   The   ‘Transition  State  mimetic   concept   ‘  has   resulted   in  a 
number of successful AIDS drugs 10, viz. Saquinavir 14, Ritonavir 12, Indinavir 
11, Nelfinavir and Amprenavir 15 etc. 





aim at  estimation of   this  quantity.  Apart   from direct  screening   for  drug­
efficacy, a­priori theoretical estimates through molecular modeling can weed 






































will   be   shown   later.   The   spectrum   of  Ki      values   also   indicate   inhibitor 
selectivity to the various Opioid receptors ,viz.. the   µ ,δ,κ    .21, 22   . Thus it is 
possible to selectively  block either of the above mentioned receptor subtypes, 
so as to get the desired pharmacological response.
It   is  possible   to   go  beyond   the    Ki    and   free  energy  estimation   to 
understand   the   intricacies   of   the   thermodynamics   of   receptor–ligand 




levels   of   inhibition,   as   a   function   of   the     equilibrium   free   ligand 
concentration.


















































































































































The above equations clearly point out that the f  max     is independent of the 
nature of receptor­ligand interactions and the binding constant (free energy). 




Firstly   we   apply   the   methodology   to   a   number   of   HIV   protease 




















































































in   the   large   values   of   Ki  and   smaller   values   of   CDP  max  (see   Eq.4.b). 
Nevertheless, in every case f max  = 0.3333, as is true for the wild strain.
We now look at the case of the same inhibitor (β   ­Naltrexamine), but 
three subtypes of Opioid receptors. viz. the   µ,δ,κ    which have their natural 
substrates  21,22  .  The  selectivity  of  binding   to  various  receptors  mentioned 





A   quantity   of   interest   in   drug   research   is   IC   (50),   viz.,   the 
concentration needed to inhibit 50 % of the receptor sites. The advantage of 
using the IC(50) standard is that f = 0.5 at IC(50) and IC(50) = K i.    Thus 
IC(50) directly leads to the estimation of  binding constants and free energy, 















































i.e.,  µ   c =    µs  . Here the suffixes   c,s   represent the free and bound (to the 
receptor) state chemical potentials. .                         











































the  ligand molecules as  if   they are   arranged on adjacent points  (nearest 
neighbor points) of  a  lattice of receptors.  It is to be noted that each receptor 
point has either single occupancy ( bound receptor )or none (vacant receptor 















































It is to be noted that this gradient (∂µ  s  /∂  p11  )  T.  never attains an 
extremum at f max = 1/3. Only the ratio of two gradients, i.e. CDP displays a 
maximum. Besides this quantity   has a universal  value depending on the 












































­RT ln Kb    = RT ln Ki     ,  where Kb  ,  Ki    are the binding and disassociation 
constants respectively. Tables 1 and  2  give the  free  energies of binding for 
a nunber of receptor­ligand systems  such as the HIV­ Protease inhibitors. 10­





see Eq. 4.b).  It is to be noted that this quantity CDPmax    estimated at  
IC(1/3) gives a direct measure of binding free energy as well as the  
chemical potential gradients,  as mentioned above.
Table   3   summarizes   the   essential   findings   about   all   the   systems 







































protease   inhibitors  we have studied are   ‘   transition   state mimetics’   ,  we 
would have thought that the estimation of the chemical potential gradient 
would help in drawing firm conclusions about the  activated complex involved 



























































.     For  many   proteins,   the   difference       between   entropy   and   enthalpic 
contributions leading to  the  native structure is about 14 kcal/mole   3  .   For 
the drugs analyzed,  the free energy change is of the same order ( see Tables 
1,2   ).    When   the   ‘native   structure   ‘   (receptor   in   active   confirmation   )   is 




































inhibition   can   be   understood   through   a   study   of   low   frequency   hinge­
vibrations of the receptor, before and after binding. This is because, the  HIV 




Lastly,  the  concentration  standard  IC(1/3)  is  just  half  of  the  often   used 
IC(50).Thus  with  less  quantity  of  lead  molecules,  we  get  more  information  which  
complements that obtained from Molecular modeling. Besides experimental error has 
very little influence (see Figure.4),if we collect accurate inhibition data around f = 1/3 
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Opioid   , µ 0.45 ­13.26 0.33
Ref  21         δ 2.57 ­12.19 5.76  10 –2
        κ 0.7 ­12.99 0.21
Captopril  
Ref  26
         ACE 1.7 ­12.44 8.71 10­2
Enalaprilet  
Ref 26























































Figure.1A  Plot  of  the  Concentration  Derivative  Product  (CDP)  Vs  concentration  of 
Inhibitor  for  five  HIV  protease  (wild  type)  inhibitors  displaying  maxima, 
Saquinavir and Ritonavir have the same inhibition constants and plots. T= 310 0K
 Figure.1B   CDP plots Vs fractional inhibition f. Note the invariance of f max  =1/3.
Figure,2A  Plot of  CDP Vs  the concentration of inhibitor for five HIV protease (mutant 
strain) inhibitors. Indinavir and Saquinavir have the same inhibition constants and 
plots.  The drug resistance of the mutant strain is seen readily in the higher values 
of  K I  and lower values of  CDP, CDP max
Figure. 2.B CDP plots Vs f . Note the location of  f max = 1/3
Figure. 3.A plot of CDP Vs concentration of inhibitor for  β  - Naltrexamine /  Opioid 
receptors µ , δ  , κ 
 Figure.3.B  CDP plots Vs f showing invariance of f max = 1/3
Figure.4  Plot  of  error  variance  of  CDP  Vs  experimental  error.  Notice  the  striking 
minimum at f = 1/3. The experimental error is Distributed as a Gaussian with zero mean 























































Fig.1. A   INHIBITOR   CONC,  nM


















































































Fig .2.A   INHIBITOR CONC FOR MUTANT  , nM
















































































Fig. 3. A INHIBITOR  CONC,  nM




















































































Fig.4   DEVIATION FROM THE  f  (max)
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